المؤلفون: João Pedro Ferreira, Susan Stienen, Kenneth Dickstein, Faiez Zannad, Jozine M. ter Maaten, Chim C. Lang, Gregoire Preud'homme, Leong L. Ng, Nilesh J. Samani, Zohra Lamiral, Patrick Rossignol, Masatake Kobayashi, Adriaan A. Voors, M. Metra, Stefan D. Anker, Dirk J. van Veldhuisen, Kevin Duarte, Nicolas Girerd

المساهمون: Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), University Medical Center Groningen [Groningen] (UMCG), University of Bergen (UiB), Department of Cardiology, Stavanger University Hospital, Department of Cardiovascular Sciences [Leicester], University of Leicester, Leicester NIHR Biomedical Research Unit in Cardiovascular Disease, University of Dundee, Ninewells Hospital and Medical School [Dundee], Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research (DZHK) partner site Berlin, University of Brescia, Civic Hospital of Brescia, This project was funded by a grant from the European Commission (FP7-242209-BIOSTAT-CHF, EudraCT 2010–020808–29). JPF, NG, PR and FZ are supported by a public grant overseen by the French National Research Agency (ANR) as part of the second 'Investissements d’Avenir' program FIGHT-HF (reference: ANR-15-RHU-0004) and by the French PIA project 'Lorraine Université d’Excellence', reference ANR-15-IDEX-04-LUE. And by Contrat de Plan Etat-Région and FEDER Lorraine., ANR-15-RHUS-0004,FIGHT-HF,Combattre l'insuffisance cardiaque(2015), ANR-15-IDEX-0004,LUE,Isite LUE(2015), European Project: 242209,EC:FP7:HEALTH,FP7-HEALTH-2009-single-stage,BIOSTAT-CHF(2010), European Project, Cardiovascular Centre (CVC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), BOZEC, Erwan, Combattre l'insuffisance cardiaque - - FIGHT-HF2015 - ANR-15-RHUS-0004 - RHUS - VALID, ISITE - Isite LUE - - LUE2015 - ANR-15-IDEX-0004 - IDEX - VALID, A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure - BIOSTAT-CHF - - EC:FP7:HEALTH2010-04-01 - 2015-03-31 - 242209 - VALID, EudraCT 2010–020808–29 - INCOMING

المصدر: ESC Heart Failure
ESC Heart Failure, Wiley, 2020, 7 (3), pp.953-963. ⟨10.1002/ehf2.12634⟩
ESC Heart Failure, Vol 7, Iss 3, Pp 953-963 (2020)
ESC Heart Failure, 7(3), 953-963. WILEY PERIODICALS, INC
ESC Heart Failure, 2020, 7 (3), pp.953-963. ⟨10.1002/ehf2.12634⟩

مصطلحات موضوعية: medicine.medical_specialty, lcsh:Diseases of the circulatory (Cardiovascular) system, BASE-LINE, Renal function, Heart failure, 030204 cardiovascular system & hematology, THERAPY, DISEASE, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Mineralocorticoid receptor, LEFT-VENTRICULAR DYSFUNCTION, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Prediction model, Internal medicine, Original Research Articles, Renin–angiotensin system, Renin, medicine, Humans, 030212 general & internal medicine, Original Research Article, Aldosterone, Mineralocorticoid Receptor Antagonists, PLASMA, business.industry, MORTALITY, medicine.disease, Prognosis, Angiotensin II, SPIRONOLACTONE, Pathophysiology, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, ANGIOTENSIN-II, ADIPOSE-TISSUE, chemistry, lcsh:RC666-701, Spironolactone, Cardiology, Cardiology and Cardiovascular Medicine, business, SYSTEM

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4867b324b8af9ffe434292e456c51d76Test
https://hdl.handle.net/11370/4a2fcf12-1631-4aa8-b37e-f73cf7a20c48Test

المؤلفون: Olivier Huttin, João Pedro Ferreira, Renaud Fay, Zohra Lamiral, Patrick Rossignol, Romain Eschalier, Christophe Bauters, Florence Pinet, Nicolas Girerd, Faiez Zannad

المصدر: ESC Heart Failure. 6:70-79

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Diastole, Odds ratio, 030204 cardiovascular system & hematology, medicine.disease, QT interval, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Heart failure, medicine, Cardiology, Myocardial fibrosis, Diastolic function, 030212 general & internal medicine, Myocardial infarction, Cardiology and Cardiovascular Medicine, Ventricular remodeling, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6959d114cf611293f56f0722e8dc02d2Test
https://doi.org/10.1002/ehf2.12359Test